Irvine, CA, United States of America

Trimedyne, Inc.


USPTO Granted Patents = 34

% Expired Patents = 14.7

Trademarks = 2

Forward Citations = 2,416

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Marvin P Loeb (18 out of 45 patents)

silverMedal L Dean Crawford (8 out of 11 patents)

bronzeMedal Hany M Hussein (7 out of 16 patents)

4.  Vahid Saadatmanesh (6 out of 6 patents)

5.  Vahid Saadat (4 out of 5 patents)

6.  Randy P Graham (3 out of 3 patents)

7.  Sanford Damasco (3 out of 3 patents)

8.  Randall J Blair (3 out of 6 patents)

9.  Stanislaw Sulek (3 out of 6 patents)

10.  Herbert Mittleman (3 out of 22 patents)

11.  Samuel M Shaolian (2 out of 108 patents)

12.  Glenn D Yeik (2 out of 2 patents)

13.  James W Pergl (2 out of 2 patents)

14.  Jeffrey J Giba (2 out of 12 patents)

15.  James A Milburn (2 out of 3 patents)


Core Competencies:
Fat Cell Lysing
Laser Energy Delivery
Tissue Ablation
Solid-State Laser
Percutaneous Laser Treatment
Expandable Laser Catheter
Medical Irradiation
Multi-Fiber Laser Device
Bio-Artificial Organ
Medication Delivery
Surgical Laser Instrument
Lateral-Lasing Fiber

34 patents:

Trimedyne, Inc. is a medical device company based in Irvine, California, specializing in innovative laser technologies for surgical applications. The organization focuses on developing advanced solutions that enhance minimally invasive procedures, particularly in the fields of urology, orthopedics, and general surgery. By leveraging cutting-edge technology, Trimedyne aims to improve patient outcomes and streamline surgical processes, positioning itself as a key player in the evolving landscape of medical devices.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Trimedyne, Inc.
34 Patents

#102 in Irvine, CA

#2,377 in California

#10,002 in US

#19,612 in the World

Irvine, CA (US)
Irvine, CA, United States of America
Forward Citations = 2,416

26 inventors:

Please report any incorrect information to [email protected]
Loading…